Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-15

Clinical Trial Update: INcrease Of VAgal TonE in CHF [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating increasing vagal tone in heart failure has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vagus nerve stimulation device

Snippet

Sponsor: BioControl Medical | Conditions: Left Ventricular Dysfunction, Heart Failure | Phase 3 | Status: TERMINATED